subject: This Year The Global Pharmaceutical Market Growth Of 4% -6% - Pharmaceutical Market - Pharmaceutical [print this page] IMSHealth company on April 20, 2010 research report released: the world Drugs Market in the next five years nearly 300 billion U.S. dollars, 2014 to reach 1.1 trillion U.S. dollars. The next 5 years and 5% to 8% annual compound growth rate reflects not only the developed countries, the main selling drugs lose patent protection by the impact of emerging countries also reflects the global Medicine Strong overall market growth. IMS Strategic Marketing Journal recently published "IMSMarketPrognosis" report published this conclusion.
Report predicts that by 2010 the global pharmaceutical Sell Amount of growth between 4 to 6%, which IMS previous prediction. In 2009, the global pharmaceutical market growth of 7.0%, reaching 837 billion U.S. dollars, the growth rate in 2008 was 4.8%.
IMS senior vice president of MurrayAitken said: "Although many markets around the world are still suffering from the impact of the recession, but the overall demand for medicines is still very strong. Built on public funds based on the developed countries of Traditional Chinese Medicine the health plan, although the drug from the payer spending growth will be increasing pressure, but the Chinese continued rapid growth in emerging markets to the world pharmaceutical market will be affected by the degree of reduction. Although the industry is access to those 10 to 15 listing of new medicines before patents expire, and low cost Generic Into peak, we estimate the net increase in the coming years will be very strong also. "
IMS analysis in this latest report, summarized by the following key factors affecting market development:
Pharmaceutical market will continue to transfer to the emerging Chinese market
2010 ~ 2014, the emerging pharmaceutical market is expected to grow from 14% growth rate of 17%, while the major developed pharmaceutical market growth of just 3% ~ 6%. 2014, the emerging pharmaceutical market growth in the amount of total pharmaceutical sales will be flat in developed pharmaceutical markets, reaching 120 000 000 000 ~ 140 billion U.S. dollars. In the past five years, this data is compared to 69 billion U.S. dollars and 126 billion U.S. dollars. U.S. will remain the world's largest pharmaceutical market in the next five-year compound annual growth rate will reach 3% -6%. Market size will be 300 billion U.S. dollars in 2009, up to 2014 360 000 000 000 ~ 390 billion U.S. dollars.
Innovative drug development cycle and market demand will drive the development of therapeutic areas
With the industry's product development areas to provide more treatment to chronic, low-cost generic drugs, those with clinical needs of large, high cost of treatment and application of new technologies for the treatment areas will have a more rapid development. During the period 2010 to 2014, cancer, Diabetes , Multiple sclerosis and anti- AIDS Drug and other therapeutic areas, including the annual growth rate of more than 10%, which mainly benefit from new drugs to market, improve attendance rates and for the development of low-cost generics to increase capital investment and other factors.
Substantially reduce health care budget will affect the market growth rate
As the global economic recession, capital markets forced to reduce investment in the medical field. To reduce the growth of pharmaceutical expenditure, Turkey, Spain, Germany, and France has announced a comprehensive limit or reduce drug use Health Insurance Project plan. Some countries will take similar measures, or putting the burden on the way to keep patients Government's balanced budget.
A large number of patent medicines expire, some of the major diseases switching to generic drugs
The next five years, mainly developed in the pharmaceutical market in the current sales of more than 142 billion U.S. dollars of patented products will face competition from generic drugs.
by: gaga
welcome to Insurances.net (https://www.insurances.net)
